Bare Platinum Coils Versus Second-generation Hydrocoils
NCT ID: NCT04988503
Last Updated: 2025-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
68 participants
INTERVENTIONAL
2021-08-30
2025-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endovascular Coiling Using Target Tetra® Coils for Small Intracranial Aneurysm
NCT06064435
Registry for Study of Coils in Intracranial Aneurysms
NCT01000675
Treatment of Ruptured Intracranial Aneurysms in China.
NCT03462433
Prospective, Multicenter Cohort Study on the Safety and Efficacy of Treatment for Middle Cerebral Artery Aneurysms
NCT04927520
PRET: Patients Prone to Recurrence After Endovascular Treatment
NCT00626912
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Second-generation hydrogel coil group
Treatment using second-generation hydrogel coils (had to constitute \> 50% of the total coil length) for ruptured cerebral aneurysms
Coil embolization
coil embolization for ruptured intracranial aneurysm with bare platinum coils or second-generation hydrogel coils
Bare platinum coil group
Treatment using bare metal coil only for ruptured cerebral aneurysms
Coil embolization
coil embolization for ruptured intracranial aneurysm with bare platinum coils or second-generation hydrogel coils
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coil embolization
coil embolization for ruptured intracranial aneurysm with bare platinum coils or second-generation hydrogel coils
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* untreated ruptured intracranial aneurysms with an anatomy such that endovascular treatment with either bare platinum or second-generation hydrogel coils was considered feasible.
* person who agreed to study
Exclusion Criteria
* combined other intracranial lesions (tumor, moyamoya disease, cerebral vascular diseases)
* ineligible for coil embolization
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pusan National University Yangsan Hospital
OTHER
Chungnam National University Sejong Hospital
OTHER
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
O-Ki Kwon
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Bundang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chungnam National University Sejong Hospital
Sejong, Chungcheongnam-do, South Korea
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, South Korea
Seoul National University Bundang Hospital
Seongnam-si, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-2012/652-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.